Loss of Spry1 Reduces Growth of BRAFV600-Mutant Cutaneous Melanoma and Improves Response to Targeted Therapy

0
41
Spry1 knockdown in three BRAFV600-mutant cutaneous melanoma cell lines markedly induced cell cycle arrest and apoptosis, repressed cell proliferation in vitro, and impaired tumor growth in vivo.
[Cell Death & Disease]
6445212 {6630899:KJHTZUEC} 1 apa 50 default 1 150543 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/